Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 5/20 | 0.59 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.59 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.59 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.59 |
| ▸ | FAP | Q12884 | 2/20 | 0.59 |
| ▸ | ACE | P12821 | 6/20 | 0.54 |
| ▸ | REN | P00797 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | PEPD | P12955 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | THPO | P40225 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2113947 | 1.00 | DPP4 (0.59) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL2113944 | 1.00 | DPP4 (0.59) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL27796855 | 0.96 | DPP7 (0.65) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL29374265 | 0.96 | DPP7 (0.65) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL2113409 | 0.96 | DPP7 (0.65) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL2113410 | 0.96 | DPP7 (0.65) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL2123080 | 0.96 | DPP7 (0.65) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL2123083 | 0.96 | DPP7 (0.65) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL31735178 | 0.91 | DPP7 (0.62) | DPP4DPP7DPP8DPP9FAP | |
| SCHEMBL10829152 | 0.91 | DPP7 (0.60) | DPP4DPP7DPP8DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245279-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245252-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR USE IN PAIN MANAGEMENT AND/OR SUBSTANCE USE DISORDERS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245244-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR MODULATING WEIGHT LOSS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245294-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245292-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT LOSS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245258-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| WO-2025245258-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025245252-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR USE IN PAIN MANAGEMENT AND/OR SUBSTANCE USE DISORDERS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025245294-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025245292-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USES THEREOF FOR MODULATING WEIGHT LOSS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025245279-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONISTS AND USE THEREFORE IN TREATMENT OF ADDICTION AND/OR PAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025245244-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR MODULATING WEIGHT LOSS | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-11945848-B2 | Chimeric inhibitor molecules of complement activation | OMEROS CORPORATION (US) | 2024-04-02 | — | — | US | disclosed |
| US-20230295252-A1 | CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION | OMEROS CORPORATION (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230159629-A1 | COMPOSITIONS AND METHOD OF MODULATING GROWTH FACTOR FUNCTION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-25 | — | — | US | disclosed |
| US-20230151084-A1 | COMPOSITIONS AND METHODS OF MODULATING B CELL RESPONSE | UNIV CASE WESTERN RESERVE (US) | 2023-05-18 | — | — | US | disclosed |
| US-11453709-B2 | Chimeric inhibitor molecules of complement activation | OMEROS CORPORATION (US) | 2022-09-27 | — | — | US | disclosed |
| US-20220185872-A1 | METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-06-16 | — | — | US | disclosed |